A probiotic by general definition is a “Live microbial feed supplement, which beneficially affects the host by improving the host’s intestinal microbial balance”. Probiotics are generally mono or mixed cultures of live microorganisms which otherwise form the major component of the gut micro flora (e.g. lactobacilli, bifidobacteria).
 
How does Probiotics beneficially affect the host?
 
Ingestion of probiotics beneficially affects the host by
  • Replenishing the depleted gut micro flora, which may have occurred due to use of antibiotics, illness, stress, travel or lifestyle changes.
  • Improving the properties of the indigenous micro flora.
Probiotic bacteria are generally, though not exclusively, lactic acid bacteria and include

Lactobacillus species like Lactobacillus acidophilus, L. casei, L. bulgaricus, L. plantarum, L. salivarius, L. rhamnosus, L. reuteri.

Bifidobacterium species like Bifidobacterium bifidum, B. longum, B. infantis. Streptococcus thermophilus, Saccharomyces boulardii.
 
What are the different types of Probiotic bacteria?
 
  • Lactobacilli and bifidobacteria :
    Lactobacilli and bifidobacteria are Gram - positive lactic acid producing bacteria that constitute a major part of the normal intestinal micro flora in humans and animals. They play an important role in resistance to colonization against exogenous, potentially pathogenic microorganisms.

  • Lactobacilli :
    Lactobacilli are Gram - positive, non - spore forming rods or coccobacilli. They have complex nutritional requirements, aero tolerant or anaerobic, acidophilic and are found in habitats rich in carbohydrate containing substrates such as the human intestinal mucosal membrane. They predominantly colonize the upper and lower small intestine.

  • Lactobacillus sporogenes :
    Lactobacillus sporogenes is present predominantly in the small intestine and helps in synthesis of B complex vitamins and Vitamin K. It also produces enzymes required in the digestion of various carbohydrates, fats, and proteins and also aids in their absorption. They have the capability of transforming into the spore form, which gives it stability and the ability to withstand high temperature, gastric acid and bile acid. Once consumed by the host, these spores germinate in the upper small intestine and produce lactic acid thereby creating an environment, which will inhibit the growth of potentially pathogenic organisms. Lactobacillus sporogenes produces biologically active L (+) lactic acid, which is completely metabolized leading to glycogen synthesis. The WHO has recommended use of lactobacillus species that produce L (+) lactic acid, especially in infant nutritional formula. Some other strains of lactobacillus like lactobacillus acidophillus produce L (-) lactic acid, which cannot be metabolized by the body and so is not preferable as a nutritional supplement.

  • Bifidobacteria :
    Bifidobacteria are nonmotile, non - spore forming, Gram - positive rods with varying appearance. Most strains are strictly anaerobic. They constitute a major part of the normal intestinal micro flora in humans throughout life.

  • Saccharomyces boulardii :
    Saccharomyces boulardii belongs to the yeast species. It is non - pathogenic and non - colonizing. It is considered transient yeast in the human intestines, which means that it does not set up residence in the mucosal membrane of the intestinal tract like the lactobacillus and bifidobacteria.

  • Streptococcus thermophilus :
    Streptococcus thermophilus are lactic acid producing aerobic gram-positive cocci. They are mainly found in the upper and lower small intestine and produce lactase enzyme, which is helpful in digestion of lactose, a sugar found in milk.
 
What is an ideal Probiotic?
 
An ideal probiotic would be one which
  • Contain bacterial species similar to those naturally present in the human intestinal flora.
  • 2. Contain probiotic species that can inhabit the whole intestine (small and large intestine).
  • 3. Should be able to protect the small and large intestine against colonization by potentially pathogenic organisms.
  • Should be able to help in proper digestion and assimilation of nutrients provided through diet throughout the gastrointestinal tract.
  • Should be able to synthesize nutrients for the host (man) like B complex vitamins and Vitamin K, and exert a beneficial effect on the host.
  • Should be able to rapidly replenish the normal gut flora in situations where the normal gut flora could be altered, as with the use of antibiotics.
  • Should not be harmful to the host in any situation.
 
What are the clinical conditions in which Probiotics can be used?
 
There are certain clinical conditions, which are associated with the depletion or alteration in the normal gut flora. In such situations, there is a plethora of symptoms, which are predominantly gastrointestinal in origin.
  • Intestinal infection (bacteria, virus, protozoa)
  • Consumption of antibiotics
  • Lactose intolerance
  • Surgery involving the bowels
  • Food fads (increased fat, carbohydrate and meat intake)
  • Inflammatory bowel disease (Ulcerative colitis, Crohn’s disease)
  • Diverticular disease of the colon
  • Irritable Bowel Syndrome
  • Recurrent aphthous ulcers or stomatitis.
 
What are the benefits of using Probiotics?
 
Arising form the changes in the intestinal milieu through the use of probiotics, a number of health benefits have been demonstrated, mostly anecdotally and to some extent in controlled clinical trials .
  • Increased resistance to infectious diseases, particularly of the intestines.
  • Decreased duration of diarrhea (antibiotic associated, travelers, infective).
  • Use in lactose intolerance (promotion of intestinal lactose digestion).
  • Increased nutritional value (better digestibility, increased absorption of vitamins and minerals).
  • Regulation of gut motility (constipation, irritable bowel syndrome).
  • Maintenance of mucosal integrity of the intestine.
  • Reduction in serum cholesterol concentration.
  • Reduction in allergy.
  • Prevention of colon cancer.
  • Reduction in carcinogen /co-carcinogen production.
 
What is a Prebiotic?
 
Prebiotics are range of non-digestible dietary supplements, which modify the balance of the intestinal micro flora, stimulating the growth and / or activity of beneficial organisms and suppressing potentially deleterious bacteria.

These supplements include lactulose, lactitol, a variety of oligosaccharides (especially fructo-oligosaccharides or FOS), and inulin. In particular, prebiotics promote the proliferation of bifidobacteria in the colon. Some of them also help in promoting the proliferation of lactobacilli in the small intestine to a certain extent.

To be effective, prebiotics should escape digestion in the upper gut, and reach the large bowel, and be utilized selectively by a restricted group of microorganisms that have been clearly identified to a health promoting properties (e.g. lactobacillus, bifidobacteria).
 
What are the different types of Prebiotic bacteria?
 
  • Streptococcus faecalis T-110 :
    Streptococcus faecalis T-110 are live mutated gram-positive, aerobic, non-spore forming cocci. They proliferate actively through the symbiotic action with B. mesentericus TO-A and C. butyricum TO-A to yield lactic acid with inhibition of growth of harmful bacteria. This lactic acid bacteria is found in the region from the upper to lower part of small intestine.

  • Clostridium butyricum TO-A :
    Clostridium butyricum TO-A are live mutated gram-positive, anaerobic, spore forming bacilli. They proliferate actively through the symbiotic action with streptococcus faecalis T-110 to yield short chain fatty acids such as butyric acid and acetic acid with a resultant decrease in intestinal pH and inhibition of growth of harmful bacteria. Additionally it acts on the intestinal tract to improve abnormal bowel movements. The short chain fatty acids also help in adjustment of water and electrolyte concentration of the intestinal tract. They also serve as source of nutrient for intestinal mucosal cells. It is found predominantly in the region from the upper small intestine to the colon.

  • Bacillius mesentericus TO-A :
    Bacillius mesentericus TO-A are live mutated gram-positive, aerobic, spore forming bacilli. They proliferate actively through the symbiotic action with streptococcus faecalis T-110. It is a spore forming bacteria and produces an amylolytic enzyme (amylase) and protease to activate proliferation of streptococcus T-110. It is also responsible for production of a nutrient, which helps in increasing the count of bifidobacteria. It is found predominantly in the small intestine.

    These three bacteria when given together, colonize in the respective places in the gastrointestinal tract and promote each other’s growth and multiplication in the human gut in a symbiotic manner. It has been found that these three species of bacteria grow together in symbiosis twenty times as much, which would not have been possible in the absence of symbiosis amongst the three species of bacteria.

    Further, in vitro studies have shown that these bacteria, when cultured together, inhibited the growth of pathogenic bacteria such as E. coli, Salmonella species, Shigella species, V. cholera and Staphylococcus aureus through their symbiotic action.

    In vitro studies also demonstrated that there was a facilitation of division and proliferation of bifidobacteria when a filtrate of B. mesentericus TO-A culture solution was added to a culture of bifidobacteria. Accelerated growth of bifidobacteria was noted.

    The three mutated bacteria have been shown to be resistant to the action of gastric juice and intestinal juice including bile. They can therefore pass unaffected through the upper GI tract (stomach and duodenum) and colonize in the lower GI tract (upper and small intestine and colon), when taken orally.

    Studies have also shown that these bacteria help in normalizing the intestinal flora by promoting the growth of beneficial bacteria and preventing the growth of harmful bacteria. In cases of intestinal infection with pathogenic bacteria, intake of these three mutated bacteria can lower the counts of the pathogenic bacteria, while simultaneously increasing the count of beneficial bacteria. This is shown by a reversal of ratio of predominant aerobic : anaerobic bacteria to a predominant anaerobic : aerobic bacterial ratio. Here the aerobic bacteria signify the potentially pathogenic organisms whereas, the anaerobic bacteria signify the beneficial resident bacteria in the intestine.

    The increased count of bifidobacteria, generated in the intestine through the action of the three mutated bacteria, produces Glutamine from NH4+ and glutamic acid in the intestine. Glutamine is the fuel for the intestinal cells and helps in maintaining the integrity of the intestinal mucosal barrier. In this manner, the colonization by potentially pathogenic microorganisms in the intestine is inhibited.
 
How does these bacteria act both as Prebiotic and Probiotic?
 
The three live bacteria namely, Streptococcus faecalis, Clostridium butyricum and Bacillus mesentericus, exert their prebiotic action in the gut by raising the counts of bifidobacteria and lactobacillus. These three live bacteria also have the property of producing lactic acid, butyric acid and acetic acid which create an acidic environment in the intestine, which in turn is detrimental to the colonization and growth of intestinal pathogenic bacteria like E. coli, Salmonella, Shigella, Clostridium, Streptococcus and Staphylococcus.

In this way these three mutated live bacteria, which are non-pathogenic and which help each other to multiply and proliferate by a process of symbiosis, act as both a PREBIOTIC (by its property of facilitating proliferation of normal gut flora bacteria like bifidobacteria and lactobacillus) and a PROBIOTIC (by its property of creating and acidic environment in the intestine and inhibiting the proliferation of potentially pathogenic organisms, thereby beneficially affecting the host).

The three bacteria continue to proliferate in the GI tract of man by a process of SYMBIOSIS, which is defined as a biological association of two or more species to their mutual benefit.